We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+13.16%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$14.9B
AUM Growth
+$995M
Cap. Flow
-$291M
Cap. Flow %
-1.95%
Top 10 Hldgs %
26.38%
Holding
2,856
New
31
Increased
336
Reduced
1,500
Closed
71

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$28.4M
2
MSFT icon
Microsoft
MSFT
+$25.6M
3
NVDA icon
NVIDIA
NVDA
+$15.2M
4
AMZN icon
Amazon
AMZN
+$11.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 27.53%
2 Financials 12.17%
3 Healthcare 11.68%
4 Consumer Discretionary 10.99%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USPH icon
1376
US Physical Therapy
USPH
$1.22B
$871K 0.01%
7,713
KROS icon
1377
Keros Therapeutics
KROS
$222M
$870K 0.01%
13,143
+1,258
+11% +$74.6K
DYN icon
1378
Dyne Therapeutics
DYN
$4.85B
$865K 0.01%
30,482
+7,549
+33% +$171K
APPN icon
1379
Appian
APPN
$2.49B
$864K 0.01%
21,619
SHC icon
1380
Sotera Health
SHC
$5.39B
$864K 0.01%
71,901
+13,273
+23% +$198K
LOGI icon
1381
Logitech
LOGI
$14.8B
$863K 0.01%
9,636
IBTX
1382
DELISTED
Independent Bank Group, Inc.
IBTX
$861K 0.01%
18,855
LZB icon
1383
La-Z-Boy
LZB
$1.64B
$859K 0.01%
22,831
GEO icon
1384
The GEO Group
GEO
$4.14B
$858K 0.01%
60,763
-1,206
-2% -$14.4K
AMPH icon
1385
Amphastar Pharmaceuticals
AMPH
$858M
$857K 0.01%
19,517
-950
-5% -$49.1K
VRTS icon
1386
Virtus Investment Partners
VRTS
$1.12B
$856K 0.01%
3,452
-175
-5% -$41.5K
VCYT icon
1387
Veracyte
VCYT
$3.59B
$854K 0.01%
38,529
IONQ icon
1388
IonQ
IONQ
$18.2B
$853K 0.01%
85,404
CBRL icon
1389
Cracker Barrel
CBRL
$1.31B
$851K 0.01%
11,698
ARDX icon
1390
Ardelyx
ARDX
$1.01B
$850K 0.01%
116,442
-5,110
-4% -$43.7K
AGIO icon
1391
Agios Pharmaceuticals
AGIO
$2.04B
$850K 0.01%
29,063
PRO
1392
DELISTED
PROS Holdings
PRO
$849K 0.01%
23,356
DVAX
1393
DELISTED
Dynavax Technologies
DVAX
$848K 0.01%
68,358
BBBY
1394
Bed Bath & Beyond
BBBY
$403M
$847K 0.01%
25,948
SITM icon
1395
SiTime
SITM
$20.7B
$845K 0.01%
9,061
ADUS icon
1396
Addus HomeCare
ADUS
$2.2B
$841K 0.01%
8,143
-245
-3% -$22.9K
ROIC
1397
DELISTED
Retail Opportunity Investments Corp.
ROIC
$840K 0.01%
65,503
AMWD
1398
DELISTED
American Woodmark
AMWD
$840K 0.01%
8,259
-440
-5% -$41.5K
KYMR icon
1399
Kymera Therapeutics
KYMR
$9.51B
$834K 0.01%
20,754
+789
+4% +$28.2K
WKC icon
1400
World Kinect Corp
WKC
$1.89B
$833K 0.01%
31,490

Similar funds

MetLife Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, MetLife Investment Management held 2,856 positions worth $14.9B, up 7.2% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.6%. MetLife Investment Management opened 31 new positions and exited 71, leaving the 2,856-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q1 2024 buy was Flutter Entertainment: 9,898 shares worth $1.98M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $128M increase.
  • MetLife Investment Management's biggest Q1 2024 reduction was Apple, cutting an estimated $28.4M.
  • MetLife Investment Management fully exited Immunogen Inc in Q1 2024, selling an estimated $3.72M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $14.9B portfolio in Q1 2024.
  • MetLife Investment Management opened 31 new positions and closed 71 in Q1 2024.
  • MetLife Investment Management's portfolio value rose 7.2% quarter-over-quarter to $14.9B.

Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.